000 01103 a2200349 4500
005 20250512092847.0
264 0 _c19681103
008 196811s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(68)92489-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBeaconsfield, P
245 0 0 _aOral contraceptives and the vital organs.
_h[electronic resource]
260 _bLancet (London, England)
_cOct 1968
300 _a832-3 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAorta
_xdrug effects
650 0 4 _aBrain
_xdrug effects
650 0 4 _aContraceptives, Oral
_xadverse effects
650 0 4 _aFemale
650 0 4 _aGlucose
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLipid Metabolism
650 0 4 _aNorethynodrel
_xpharmacology
650 0 4 _aRats
700 1 _aAbrams, M E
700 1 _aGinsburg, J
700 1 _aRainsbury, R
773 0 _tLancet (London, England)
_gvol. 2
_gno. 7572
_gp. 832-3
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(68)92489-6
_zAvailable from publisher's website
999 _c4181033
_d4181033